サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676186

COVID-19治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global COVID-19 Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
COVID-19治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

COVID-19治療薬の世界市場規模は、2024年の248億米ドルから2033年には505億3,000万米ドルに成長すると予測され、2026～2033年の予測期間中に8.23%の堅調な年間平均成長率（CAGR）を示します。

COVID-19治療薬市場は、世界の医療界が現在進行中のパンデミックへの対応を続けているため、かつてない成長を遂げています。COVID-19の治療薬には、抗ウイルス薬、モノクローナル抗体、症状の管理と重症度の軽減を目的とした支持療法が含まれます。COVID-19と闘うための効果的な治療薬の緊急の必要性が、研究開発への多額の投資を促し、市場の拡大をさらに促進しています。

技術の進歩はCOVID-19治療薬市場の将来を形作る上で重要な役割を果たしています。人工知能や機械学習の利用を含む創薬・開発プロセスの革新は、潜在的な治療薬候補の同定を加速させています。さらに、適応検査デザインなどの臨床検査手法の進歩により、新たな治療薬の評価効率が向上しています。製薬企業と研究機関の協力とデータの共有が進むにつれて、COVID-19治療薬市場は急速な進歩を遂げ、効果的な治療薬選択肢の利用可能性が高まるとみられます。

さらに、世界の健康の安全保障と準備の重視の高まりが、COVID-19治療薬市場の成長軌道に影響を与えています。政府や保健機関が将来のパンデミックに対処するための装備の重要性を認識しているため、新興感染症に対応して迅速に展開できる治療薬に対する需要が高まっています。この動向は、COVID-19治療薬の強固なサプライチェーンと流通網を開発するための官民間の協力を促進しています。市場が進化を続ける中、技術、世界の連携、準備戦略の統合が成功の重要な促進要因となると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をクライアントに提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 COVID-19治療薬産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19治療薬の世界市場分析：薬剤タイプ別

  • 薬剤タイプ別概要
  • 薬剤タイプ別過去・予測データ分析
  • 抗ウイルス薬
  • 免疫調節薬
  • コルチコステロイド
  • モノクローナル抗体
  • その他

第6章 COVID-19治療薬の世界市場分析：投与経路別

  • 投与経路別概要
  • 投与経路別過去・予測データ分析
  • 経口
  • 静脈内投与
  • その他

第7章 COVID-19治療薬の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 COVID-19治療薬の世界市場分析：患者属性別

  • 患者属性別概要
  • 患者属性別過去・予測データ分析
  • 小児
  • 成人
  • 高齢者

第9章 COVID-19治療薬の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 COVID-19治療薬企業の競合情勢

  • COVID-19治療薬市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Pfizer Inc.
  • Moderna Inc.
  • Gilead Sciences Inc.
  • Regeneron Pharmaceuticals Inc.
  • Eli Lilly And Company
  • Johnson & Johnson
  • AstraZeneca PLC
  • BioNTech SE
  • GlaxoSmithKline Plc
  • Sanofi S.A.
  • Roche Holding AG
  • Merck & Co. Inc.
  • Novartis AG
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Type (USD MN)
  • Antiviral Drugs Market Sales By Geography (USD MN)
  • Immune Modulators Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospitals Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Analysis By Patient Demographics (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Global Covid 19 Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Covid 19 Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Covid 19 Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Patient Demographics
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Type (USD MN)
  • Antiviral Drugs Market Sales By Geography (USD MN)
  • Immune Modulators Market Sales By Geography (USD MN)
  • Corticosteroids Market Sales By Geography (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Intravenous Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospitals Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Analysis By Patient Demographics (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Geriatric Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR112110678

Global Covid 19 Therapeutics Market size is anticipated to grow from USD 24.8 Billion in 2024 to USD 50.53 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.23% during the forecast period of 2026 to 2033.

The COVID-19 Therapeutics Market is experiencing unprecedented growth as the global healthcare community continues to respond to the ongoing pandemic. Therapeutics for COVID-19 include antiviral medications, monoclonal antibodies, and supportive care treatments aimed at managing symptoms and reducing the severity of the disease. The urgent need for effective treatments to combat COVID-19 is driving significant investments in research and development, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the COVID-19 therapeutics market. Innovations in drug discovery and development processes, including the use of artificial intelligence and machine learning, are accelerating the identification of potential therapeutic candidates. Additionally, advancements in clinical trial methodologies, such as adaptive trial designs, are enhancing the efficiency of evaluating new treatments. As pharmaceutical companies and research institutions continue to collaborate and share data, the COVID-19 therapeutics market is likely to see rapid advancements and increased availability of effective treatment options.

Moreover, the growing emphasis on global health security and preparedness is influencing the COVID-19 therapeutics market's growth trajectory. As governments and health organizations recognize the importance of being equipped to handle future pandemics, there is a rising demand for therapeutics that can be rapidly deployed in response to emerging infectious diseases. This trend is driving collaboration between public and private sectors to develop robust supply chains and distribution networks for COVID-19 therapeutics. As the market continues to evolve, the integration of technology, global collaboration, and preparedness strategies will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Drug Type

  • Antiviral Drugs
  • Immune Modulators
  • Corticosteroids
  • Monoclonal Antibodies
  • Others

By Route Of Administration

  • Oral
  • Intravenous
  • Others

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Patient Demographics

  • Pediatric
  • Adult
  • Geriatric
  • COMPANIES PROFILED
  • Pfizer Inc.
  • Moderna Inc.
  • Gilead Sciences Inc.
  • Regeneron Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • AstraZeneca PLC
  • BioNTech SE
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Roche Holding AG
  • Merck & Co. Inc.
  • Novartis AG
  • AbbVie Inc.
  • Bristol-Myers Squibb Company.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COVID 19 THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Type
    • 3.7.2 Market Attractiveness Analysis By Route Of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Patient Demographics
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COVID 19 THERAPEUTICS MARKET ANALYSIS BY DRUG TYPE

  • 5.1. Overview By Drug Type
  • 5.2. Historical and Forecast Data Analysis By Drug Type
  • 5.3. Antiviral Drugs Historic and Forecast Sales By Regions
  • 5.4. Immune Modulators Historic and Forecast Sales By Regions
  • 5.5. Corticosteroids Historic and Forecast Sales By Regions
  • 5.6. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL COVID 19 THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route Of Administration
  • 6.2. Historical and Forecast Data Analysis By Route Of Administration
  • 6.3. Oral Historic and Forecast Sales By Regions
  • 6.4. Intravenous Historic and Forecast Sales By Regions
  • 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL COVID 19 THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospitals Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL COVID 19 THERAPEUTICS MARKET ANALYSIS BY PATIENT DEMOGRAPHICS

  • 8.1. Overview By Patient Demographics
  • 8.2. Historical and Forecast Data Analysis By Patient Demographics
  • 8.3. Pediatric Historic and Forecast Sales By Regions
  • 8.4. Adult Historic and Forecast Sales By Regions
  • 8.5. Geriatric Historic and Forecast Sales By Regions

9. GLOBAL COVID 19 THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COVID 19 THERAPEUTICS COMPANIES

  • 10.1. Covid 19 Therapeutics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF COVID 19 THERAPEUTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Moderna Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Gilead Sciences Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Regeneron Pharmaceuticals Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Eli Lilly And Company
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Johnson & Johnson
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. AstraZeneca PLC
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. BioNTech SE
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. GlaxoSmithKline Plc
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Sanofi S.A.
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Roche Holding AG
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Merck & Co. Inc.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Novartis AG
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. AbbVie Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Bristol-Myers Squibb Company
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies